SONOTIZE
SONOTIZE
Industry:
Digital Entertainment Media And Entertainment Music
Founded:
2015-11-20
Address:
Denver, Colorado, United States
Country:
United States
Website Url:
http://www.sonotize.com
Total Employee:
1+
Status:
Active
Total Funding:
435 K USD
Technology used in webpage:
SPF IPv6 Google Apps For Business Cloudflare Hosting Cloudflare DNS Pound Sterling Japanese Yen Hostgator Mail
Current Advisors List
Current Employees Featured
Founder
Investors List
Rockies Venture Club
Rockies Venture Club investment in Angel Round - Sonotize
Official Site Inspections
http://www.sonotize.com
- Host name: 104.21.37.12
- IP address: 104.21.37.12
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sonotize"
Our Company - SaNOtize
The Company SaNOtize, based in Vancouver, Canada, is developing and commercializing products that deliver the natural antimicrobial properties of nitric oxide (NO) for use in common viral, bacterial, and fungal infections. SaNOtize …See details»
SaNOtize - Crunchbase Company Profile & Funding
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections. The company develops a Nitric Oxide Releasing Solution platform technology to treat and prevent microbial …See details»
Board of Directors - SaNOtize
Elaine Campbell A retired senior executive with over 30 years of experience in the pharmaceutical and chemical industry, Elaine has broad commercial experience in sales and marketing, …See details»
SaNOtize Company Profile 2024: Valuation, Funding
SaNOtize General Information Description. Developer of a nitric oxide-releasing technology designed to treat upper respiratory and dermal infections. The company's technology provides first-line non-antibiotic antimicrobials for use …See details»
SaNOtize - Funding, Financials, Valuation & Investors - Crunchbase
SaNOtize is a biotech company using a platform technology for topical to treat upper respiratory and dermal infections. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
SaNOtize to Evaluate Nitric Oxide Nasal Spray for the Treatment of ...
Feb 13, 2024 SaNOtize has begun enrollment of 186 patients in a Phase 2 study in Canada that will assess the safety and efficacy of NONS compared to placebo as a treatment for RARS. …See details»
Vancouver company’s anti-COVID-19 nasal spray to …
Jan 11, 2021 A Vancouver-based company called SaNOtize has created a nasal spray that it says can stop COVID-19 from spreading throughout the body and even prevent someone from getting the virus. “The ...See details»
SaNOtize Announces $24 Million in Series B Funding to Advance …
Aug 24, 2022 About SaNOtize SaNOtize Research & Development Corp. is a pharmaceutical company based in Vancouver, BC, commercializing the multi-faceted antimicrobial properties …See details»
SaNOtize Obtains Health Canada Approval to Begin Enrolment for …
Jun 23, 2021 The SaNOtize treatment is based on nitric oxide (NO), a natural nanomolecule produced by the human body with proven anti-microbial properties shown to have a direct …See details»
Newly Published Phase 3 Study in People with COVID-19 Shows …
Jul 13, 2022 About SaNOtize. SaNOtize Research & Development Corp. is a pharmaceutical company based in Vancouver, BC, commercializing the multi-faceted antimicrobial properties …See details»
Our Technology - SaNOtize
SaNOtize’s key innovation is the development of solutions that locally release nitric oxide (NO) in concentrations with potential antimicrobial effects against viruses, bacteria, and fungi. Nitric …See details»
Sanotize Obtains Health Canada Approval To Begin Enrolment For …
Jun 23, 2021 VANCOUVER, BC–(BUSINESS WIRE)–SaNOtize Research and Development Corporation (“SaNOtize” or “the company”) announced that it has received approval from …See details»
SARS-CoV-2 accelerated clearance using a novel nitric ... - The …
Jul 12, 2022 Prior to this study, evidence from several sources, including book citations, journal publications and SaNOtize's laboratory investigations have recognized the antiviral effect of …See details»
SaNOtize Ramps Up Anti-COVID Nasal Spray Production To Keep …
Nov 30, 2021 SaNOtize CEO Dr. Gilly Regev visited Israel earlier this month as she inspected the increase in manufacturing production of her company’s antiviral nasal spray, Enovid, which …See details»
SaNOtize Obtains Health Canada Approval to Begin Enrolment for …
Jun 23, 2021 SaNOtize Research and Development Corporation (“SaNOtize” or “the company”) announced that it has received approval from Health Canada to proceed with enrollment of …See details»
We want to be a product approved for Canadians: SaNOtize CEO …
U.K. clinical trials for Vancouver’s SaNOtize have confirmed that its nasal spray reduced SARS-CoV-2 log viral load by more than 95 per cent in infected part...See details»
Clinical Study Suggests SaNOtize Nitric Oxide Nasal Spray Is …
May 11, 2022 About SaNOtize. SaNOtize Research & Development Corp. is a pharmaceutical company based in Vancouver, BC, commercializing the multi-faceted antimicrobial properties …See details»
Clinical Study Suggests SaNOtize Nitric Oxide Nasal Spray Is …
May 11, 2022 In India, NONS received an emergency use approval by the Central Drugs Standard Control Organization (CDSCO) for treatment of adult patients with COVID-19 who …See details»
Phase 3 Clinical Trial Confirms SaNOtize’s ... - Business Wire
Feb 9, 2022 Phase 3 trial reached primary endpoint and demonstrated a reduction in SARS-CoV-2 log viral load in COVID-19 patients by more than 94% within 24 hours of treatment, and …See details»